(2R/2S,4R)-2-(naphth-1-yl)thiazolidine-4-carboxylic acid

ID: ALA4281605

Chembl Id: CHEMBL4281605

Cas Number: 746677-85-0

PubChem CID: 11196223

Max Phase: Preclinical

Molecular Formula: C14H13NO2S

Molecular Weight: 259.33

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)[C@@H]1CSC(c2cccc3ccccc23)N1

Standard InChI:  InChI=1S/C14H13NO2S/c16-14(17)12-8-18-13(15-12)11-7-3-5-9-4-1-2-6-10(9)11/h1-7,12-13,15H,8H2,(H,16,17)/t12-,13?/m0/s1

Standard InChI Key:  WSGHWUWDWJRTFR-UEWDXFNNSA-N

Alternative Forms

Associated Targets(non-human)

ACP5 Tartrate-resistant acid phosphatase type 5 (16 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 259.33Molecular Weight (Monoisotopic): 259.0667AlogP: 2.63#Rotatable Bonds: 2
Polar Surface Area: 49.33Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.21CX Basic pKa: 6.78CX LogP: 0.59CX LogD: -0.03
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.87Np Likeness Score: -0.18

References

1. Hussein WM, Feder D, Schenk G, Guddat LW, McGeary RP..  (2018)  Purple acid phosphatase inhibitors as leads for osteoporosis chemotherapeutics.,  157  [PMID:30107365] [10.1016/j.ejmech.2018.08.004]

Source